1. Home
  2. RCEL vs TRAK Comparison

RCEL vs TRAK Comparison

Compare RCEL & TRAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • TRAK
  • Stock Information
  • Founded
  • RCEL 2020
  • TRAK 1990
  • Country
  • RCEL United States
  • TRAK United States
  • Employees
  • RCEL N/A
  • TRAK N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • TRAK EDP Services
  • Sector
  • RCEL Health Care
  • TRAK Technology
  • Exchange
  • RCEL Nasdaq
  • TRAK Nasdaq
  • Market Cap
  • RCEL 310.6M
  • TRAK 351.4M
  • IPO Year
  • RCEL N/A
  • TRAK 1998
  • Fundamental
  • Price
  • RCEL $12.87
  • TRAK $22.66
  • Analyst Decision
  • RCEL Hold
  • TRAK Strong Buy
  • Analyst Count
  • RCEL 3
  • TRAK 1
  • Target Price
  • RCEL $16.50
  • TRAK $24.00
  • AVG Volume (30 Days)
  • RCEL 112.9K
  • TRAK 58.2K
  • Earning Date
  • RCEL 11-07-2024
  • TRAK 11-14-2024
  • Dividend Yield
  • RCEL N/A
  • TRAK 0.28%
  • EPS Growth
  • RCEL N/A
  • TRAK 7.98
  • EPS
  • RCEL N/A
  • TRAK 0.30
  • Revenue
  • RCEL $60,040,000.00
  • TRAK $20,834,350.00
  • Revenue This Year
  • RCEL $34.73
  • TRAK $14.70
  • Revenue Next Year
  • RCEL $54.61
  • TRAK $15.00
  • P/E Ratio
  • RCEL N/A
  • TRAK $78.33
  • Revenue Growth
  • RCEL 32.24
  • TRAK 7.18
  • 52 Week Low
  • RCEL $7.51
  • TRAK $9.30
  • 52 Week High
  • RCEL $18.93
  • TRAK $23.99
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 64.34
  • TRAK 65.45
  • Support Level
  • RCEL $11.63
  • TRAK $19.56
  • Resistance Level
  • RCEL $13.82
  • TRAK $22.40
  • Average True Range (ATR)
  • RCEL 0.86
  • TRAK 1.05
  • MACD
  • RCEL 0.09
  • TRAK 0.26
  • Stochastic Oscillator
  • RCEL 74.46
  • TRAK 74.76

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software as a service provider with extensive capabilities that gives their customers an easy, cost-efficient way to expand their services to their benefit. The company and its subsidiaries develop, market, and support proprietary software products. These products assist the management of business operations, which helps clients to make more informed decisions. The company also provides a cloud-based solution to remain in compliance with business records and regulatory requirements. The firm's services comprise implementation, business optimization, outsourcing, technical services, education, and application hosting.

Share on Social Networks: